Literature DB >> 18514600

Cholecystectomy in sickle cell disease patients: is there more acute chest syndrome after laparoscopy? A case controlled study.

B Diarra1, J Roudié, A Coulibaly, F Ehua Somian, J-B Kanga-Miessan, D Franco.   

Abstract

Laparoscopy is increasingly being recommended in order to reduce postoperative complications among sickle cell disease patients undergoing cholecystectomy. Acute chest syndrome is the most deadly of these complications. The purpose of this study was to assess if laparoscopic approach reduces postoperative complications related to sickle cell disease after cholecystectomy. A retrospective study of records of sickle cell patients who underwent cholecystectomy for cholelithiasis, from January 1990 to December 2005 was conducted. 136 sickle cell patients underwent surgery: 47 (34.5%) by laparoscopy and 89 (63.5%) by laparotomy. The mean operative time was 71.4+/-18.9 min in the laparoscopy group and 61.2+/-15.3 min in the laparotomy group (non-significant difference). The mortality was not significantly different between the two groups: one patient died in the open cholecystectomy group but no death occurred in the laparoscopic one. The morbidity related to the sickle cell disease was significantly higher in the laparoscopy group [n=5 (10.5%)] than in the laparotomy group [n=4 (4.5%)] (p=0.04). This difference was associated with a higher rate of acute chest syndrome in the laparoscopy group [n=4 (8, 5%)] compared to that in the laparotomy group [n=1 (1.1%)] (p=0.01). There were more complications related to sickle cell disease in the laparoscopy group due to acute chest syndrome. Thus, these data should be confirmed in further randomized studies which must be undertaken.

Entities:  

Mesh:

Year:  2008        PMID: 18514600     DOI: 10.1016/j.ijsu.2008.03.009

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  5 in total

1.  Low-impact laparoscopic cholecystectomy is associated with decreased postoperative morbidity in patients with sickle cell disease.

Authors:  Nicola de'Angelis; Solafah Abdalla; Maria Clotilde Carra; Vincenzo Lizzi; Aleix Martínez-Pérez; Anoosha Habibi; Pablo Bartolucci; Frédéric Galactéros; Alexis Laurent; Francesco Brunetti
Journal:  Surg Endosc       Date:  2017-11-02       Impact factor: 4.584

Review 2.  Laparoscopic cholecystectomy for cholelithiasis in children with sickle cell disease.

Authors:  Yousef Al Talhi; Bader Hamza Shirah; Muteb Altowairqi; Yasmin Yousef
Journal:  Clin J Gastroenterol       Date:  2017-05-29

Review 3.  Indications for transfusion in the management of sickle cell disease.

Authors:  Hyojeong Han; Lisa Hensch; Venée N Tubman
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

4.  Laparoscopic cholecystectomy in 427 adults with sickle cell disease: a single-center experience.

Authors:  Abdulrahman S Al-Mulhim; Abdulmohsen A Al-Mulhim
Journal:  Surg Endosc       Date:  2009-05-15       Impact factor: 4.584

5.  A case series of cholecystectomy in Jamaican sickle cell disease patients - The need for a new strategy.

Authors:  Pierre-Anthony Leake; Marvin Reid; Joseph Plummer
Journal:  Ann Med Surg (Lond)       Date:  2017-02-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.